In December 2021, APFED reported that the U.S. Food and Drug Administration (FDA) denied the TAK-721 New Drug Application, indicating the drug – a budesonide ...

The Med ...

APFED is partnering with the Allergy & Asthma Network, the American Lung Association, and the Asthma and Allergy Foundation of America to co-host a virtual ...

We invite community members to join us in advocating for the Medical Nutrition Equity Act ...